GentriSure products offer highly characterized controls containing polymorphisms for four genes.

LGC Promochem entered into an agreement with Gentris for the marketing and distribution of GentriSure range of Human Genomic Reference Controls (HGRC) in Europe and India.

The GentriSure products offer highly characterized controls for a variety of key genetic polymorphisms. Currently available controls contain polymorphisms for CYP2D6, CYP2C19, CYP2C9, and VKORC1 genes.

The controls are isolated from B-lymphoblastoids derived from individual donors. DNA sequences are verified using bi-directional sequencing. There are no artificial DNA sequences introduced to the cell lines so the controls are virtually identical to genomic DNA isolated from typical patient samples.

Previous articleDNA Markers for Prediabetic Side Effects to Psychotropic Drugs Revealed
Next articleAlkermes To Be Exclusive Supplier for Lilly’s AIR® Inhaled Insulin System